Candidate biomarkers in psychiatric disorders: state of the field

A Abi‐Dargham, SJ Moeller, F Ali… - World …, 2023 - Wiley Online Library
The field of psychiatry is hampered by a lack of robust, reliable and valid biomarkers that can
aid in objectively diagnosing patients and providing individualized treatment …

Functional connectomics in depression: insights into therapies

Y Chai, YI Sheline, DJ Oathes, NL Balderston… - Trends in Cognitive …, 2023 - cell.com
Depression is a common mental disorder characterized by heterogeneous cognitive and
behavioral symptoms. The emerging research paradigm of functional connectomics has …

Plasticity of synapses and reward circuit function in the genesis and treatment of depression

SM Thompson - Neuropsychopharmacology, 2023 - nature.com
What changes in brain function cause the debilitating symptoms of depression? Can we use
the answers to this question to invent more effective, faster acting antidepressant drug …

Efficacy of vortioxetine on anhedonia: results from a pooled analysis of short-term studies in patients with major depressive disorder

RS McIntyre, H Loft, MC Christensen - … Disease and Treatment, 2021 - Taylor & Francis
Purpose Anhedonia is a core symptom of major depressive disorder (MDD), which has
important functional consequences for the patient. This post hoc analysis investigated the …

Brain connectivity in major depressive disorder: a precision component of treatment modalities?

A Tura, R Goya-Maldonado - Translational Psychiatry, 2023 - nature.com
Major depressive disorder (MDD) is a very prevalent mental disorder that imposes an
enormous burden on individuals, society, and health care systems. Most patients benefit …

Natural psychedelics in the treatment of depression; a review focusing on neurotransmitters

S Jahanabadi, S Amiri, M Karkeh-Abadi, A Razmi - Fitoterapia, 2023 - Elsevier
Natural psychedelic compounds are emerging as potential novel therapeutics in psychiatry.
This review will discuss how natural psychedelics exert their neurobiological therapeutic …

Beyond the serotonin deficit hypothesis: communicating a neuroplasticity framework of major depressive disorder

CE Page, CN Epperson, AM Novick, KA Duffy… - Molecular …, 2024 - nature.com
The serotonin deficit hypothesis explanation for major depressive disorder (MDD) has
persisted among clinicians and the general public alike despite insufficient supporting …

Computational approaches to treatment response prediction in major depression using brain activity and behavioral data: A systematic review

P Karvelis, CE Charlton, SG Allohverdi… - Network …, 2022 - direct.mit.edu
Major depressive disorder is a heterogeneous diagnostic category with multiple available
treatments. With the goal of optimizing treatment selection, researchers are developing …

Association of executive function with suicidality based on resting-state functional connectivity in young adults with subthreshold depression

JY Yun, SH Choi, S Park, JH Jang - Scientific Reports, 2023 - nature.com
Subthreshold depression (StD) is associated an increased risk of developing major
depressive disorder (MDD) and suicidality. Suicidality could be linked to distress intolerance …

Breakthroughs and challenges for generating brain network-based biomarkers of treatment response in depression

S Prompiengchai, K Dunlop - Neuropsychopharmacology, 2024 - nature.com
Abstract Treatment outcomes widely vary for individuals diagnosed with major depressive
disorder, implicating a need for deeper understanding of the biological mechanisms …